Topiramate Tablet, Film Coated
Product Images NDC 70518-1953

5 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 70518-1953). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structured Product Formula For Topiramate (59862b94 C1fb 465a 9a53 Ad5174f9d129 01)

Structured Product Formula For Topiramate (59862b94 C1fb 465a 9a53 Ad5174f9d129 01)
Chemical structure of topiramate, showing its molecular arrangement with multiple oxygen atoms, methyl groups, and a sulfonamide moiety.*
FDA Label Image

Structured Product Formula For Topiramate (59862b94 C1fb 465a 9a53 Ad5174f9d129 02)

Structured Product Formula For Topiramate (59862b94 C1fb 465a 9a53 Ad5174f9d129 02)
A line graph showing cumulative rates for time to first seizure over a period of 500 days, comparing two dosage groups of topiramate: 50 mg/day (solid line) and 400 mg/day (dashed line). The graph indicates that the group receiving 400 mg/day has a lower cumulative seizure rate over time compared to the 50 mg/day group.*
FDA Label Image

Topiramate Tablets Usp (59862b94 C1fb 465a 9a53 Ad5174f9d129 03)

Topiramate Tablets Usp (59862b94 C1fb 465a 9a53 Ad5174f9d129 03)
Bar graph depicting the change from baseline to double-blind phase in average monthly migraine period rate (+SE) for topiramate at doses of 50 mg/day, 100 mg/day, and 200 mg/day compared with placebo, based on data from two studies (Study 11 and Study 12) with varying sample sizes. Statistical significance markers indicate p-values below 0.010 and 0.001 for topiramate doses 100 mg/day and 200 mg/day.*
FDA Label Image

Mm1 (Topiramate 100mg 70518 1953 00)

Mm1 (Topiramate 100mg 70518 1953 00)
Topiramate 100 mg tablet film-coated oral dosage packaging label. The label shows a quantity of 30 tablets, with NDC 70518-1953-00, repackaged by RemedyRepack Inc., Indiana, PA. The manufacturer is Zydus Pharm, Pennington, NJ, with MFG NDC 68382-0140-05. Storage instructions and usual dosage note are also present.*
FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Topiramate 100 mg film-coated tablets in a quantity of 30, repackaged by RemedyRepack Inc. The white label includes the product name, strength, dosage form, and manufacturer details. It also contains storage instructions and a QR code, with a note to keep medication out of children's reach. The original manufacturer listed is Zydus Pharm, Pennington, NJ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.